FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Scott

Research Profile

Chemicals & Drugs

Procedures

Living Beings

Anatomy

Concepts & Ideas

Disorders

Neoplasms

Co-author Network

Publications

TOP 3
Nathan Lawrentschuk; Sze Ting Lee; Andrew M Scott
Current role of PET, CT, MR for invasive bladder cancer.
Gerald Js Tan; Salvatore U Berlangieri; Sze Ting Lee; Andrew M Scott
Periarticular FDG Uptake on PET/CT in Malignant Melanoma-Metastatic or Misleading?
Nicholas J Clemons; Daniel Croagh; Christina M Fennell; Carmel Murone; Andrew M Scott; Anjali Tikoo; David H Wang; DAVID WATKINS; Wayne A Phillips
Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Scott (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nathan Lawrentschuk; Sze Ting Lee; Andrew M Scott
Current role of PET, CT, MR for invasive bladder cancer.
Current urology reports 2013;14(2):84-9.
2013: Gerald Js Tan; Salvatore U Berlangieri; Sze Ting Lee; Andrew M Scott
Periarticular FDG Uptake on PET/CT in Malignant Melanoma-Metastatic or Misleading?
Annals of the Academy of Medicine, Singapore 2013;42(3):159-60.
2012: Nicholas J Clemons; Daniel Croagh; Christina M Fennell; Carmel Murone; Andrew M Scott; Anjali Tikoo; David H Wang; DAVID WATKINS; Wayne A Phillips
Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus.
American journal of physiology. Gastrointestinal and liver physiology 2012;303(12):G1335-46.
2012: Vijayaragavan Muralidharan; Andrew M Scott; Marco Kwok; Lawrence Lau; Sze Ting Lee; christopher christophi
Prognostic ability of 18F-FDG PET/CT in the assessment of colorectal liver metastases.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(9):1345-51.
2012: Angus P R Johnston; Marloes M J Kamphuis; Edouard C Nice; Andrew M Scott; Georgina K Such; Joan K Heath; Frank Caruso
Targeting cancer cells: controlling the binding and internalization of antibody-functionalized capsules.
ACS nano 2012;6(8):6667-74.
2012: Joe H Chang; David Clouston; Ian D Davis; Sylvia J Gong; Christopher S Hamilton; Nigel J Anderson; Damien Bolton; Sze Ting Lee; Daryl Lim Joon; Andrew M Scott; Vincent Khoo
Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans.
International journal of radiation oncology, biology, physics 2012;83(5):e691-6.
2012: Evelyn Laurens; Graeme J O'Keefe; Angela Rigopoulos; Andrew M Scott; Henri Tochon-Danguy; Jonathan M White; Shinn Dee Yeoh; Diana Cao; Glenn A Cartwright; Uwe Ackermann
Radiolabelling and evaluation of novel haloethylsulfoxides as PET imaging agents for tumor hypoxia.
Nuclear medicine and biology 2012;39(6):871-82.
2012: Sze Ting Lee; Nathan Lawrentschuk; Andrew M Scott
PET in prostate and bladder tumors.
Seminars in nuclear medicine 2012;42(4):231-46.
2012: Andrew M Scott; Jedd D Wolchok; Lloyd J Old
Antibody therapy of cancer.
Nature reviews. Cancer 2012;12(4):278-87.
2012: Nathan Lawrentschuk; Deborah Sasges; Andrew M Scott; Robert Tasevski; Robert Abouassaly; Ian D Davis
Oncology health information quality on the Internet: a multilingual evaluation.
Annals of surgical oncology 2012;19(3):706-13.
2012: Olga Shimoni; Yan Yan; Alexander N Zelikin; Joan K Heath; Edouard C Nice; Almar Postma; Andrew M Scott; Frank Caruso
Macromolecule functionalization of disulfide-bonded polymer hydrogel capsules and cancer cell targeting.
ACS nano 2012;6(2):1463-72.
2012: Andrew M Scott; James P Allison; Jedd D Wolchok
Monoclonal antibodies in cancer therapy.
Cancer immunity 2012;12():14.
2012: Andrew M Scott; Charles Baum; Nicoletta Brega; Rodney J Hicks; Timothy J McCarthy; Paul L Mitchell; Graeme O'Keefe; Aurora Poon; Tim Saunder; Guy C Toner
Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignancies.
EJNMMI research 2012;2(1):31.
2012: Andrew R McLeish; Amanda J Byrne; Sze Ting Lee; Andrew M Scott
Impact of ¹⁸F-FDG-PET in decision making for liver metastectomy of colorectal cancer.
ANZ journal of surgery 2012;82(1-2):30-5.
2012: Nathalie S Dhomen; John Mariadason; Niall Tebbutt; Andrew M Scott
Therapeutic targeting of the epidermal growth factor receptor in human cancer.
Critical reviews in oncogenesis 2012;17(1):31-50.
2011: Anna N Cvrljevic; Frank B Furnari; Deliang Guo; Nick J Hoogenraad; Amelia J Johnston; Paul Martinello; Paul S Mischel; Lisa Pike; Andrew M Scott; Min Wu; David Akhavan; Webster K Cavenee; Terrance G Johns
Activation of Src induces mitochondrial localisation of de2-7EGFR (EGFRvIII) in glioma cells: implications for glucose metabolism.
Journal of cell science 2011;124(Pt 17):2938-50.
2011: Vinochani Pillay; Hui K Gan; Andrew M Scott
Antibodies in oncology.
New biotechnology 2011;28(5):518-29.
2011: Nathan Lawrentschuk; Fook T Lee; Angela Mountain; Graeme O'Keefe; Anthony T Papenfuss; Angela Rigopoulos; Damien Michael Bolton; Ian D Davis; Gareth Jones; Andrew M Scott
Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.
Urologic oncology 2011;29(4):411-20.
2011: Malcolm Feigen; Katheryn Churcher; Catherine Lawford; Sze Ting Lee; Andrew M Scott; Eddy Zupan; Chris Hamilton
Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation.
Journal of medical imaging and radiation oncology 2011;55(3):320-32.
2011: Noga Kozer; Marcus P Kelly; Suzanne Orchard; Antony W Burgess; Andrew M Scott; Andrew H A Clayton
Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.
Biochemistry 2011;50(18):3581-90.
2011: Joe H Chang; Daryl Lim Joon; Sze Ting Lee; Sylvia J Gong; Andrew M Scott; Ian D Davis; David Clouston; Damien Bolton; Christopher S Hamilton; Vincent S Khoo
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;99(2):187-92.
2011: David S Binns; Andrea Pirzkall; Wei Yu; Jason Callahan; Linda Mileshkin; Peter Conti; Andrew M Scott; David Macfarlane; Bernard M Fine; Rodney J Hicks
Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer.
European journal of nuclear medicine and molecular imaging 2011;38(4):642-50.
2010: Marloes M J Kamphuis; Angus P R Johnston; Georgina K Such; Henk H Dam; Richard A Evans; Andrew M Scott; Edouard C Nice; Joan K Heath; Frank Caruso
Targeting of cancer cells using click-functionalized polymer capsules.
Journal of the American Chemical Society 2010;132(45):15881-3.
2010: Terrance G Johns; Michael J McKay; Anna N Cvrljevic; Hui K Gan; Caitlin Taylor; Huiling Xu; Fiona E Smyth; Andrew M Scott
MAb 806 enhances the efficacy of ionizing radiation in glioma xenografts expressing the de2-7 epidermal growth factor receptor.
International journal of radiation oncology, biology, physics 2010;78(2):572-8.
2010: Arun Azad; Fiona Chionh; Andrew M Scott; Szeting T Lee; Salvatore U Berlangieri; Shane White; Paul L Mitchell
High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2010;12(4):443-51.
2010: James S Olver; Graeme O'Keefe; Gareth R Jones; Graham D Burrows; Henri Tochon-Danguy; Uwe Ackermann; Andrew M Scott; Trevor R Norman
Dopamine D(1) receptor binding in the anterior cingulate cortex of patients with obsessive-compulsive disorder.
Psychiatry research 2010;183(1):85-8.
2010: Stefan Peinert; H Miles Prince; P M Guru; Michael H Kershaw; Mark J Smyth; Joseph A Trapani; P Gambell; S Harrison; Andrew M Scott; F E Smyth; Phillip K Darcy; Kellie M Tainton; P Neeson; David S Ritchie; D Hönemann
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen.
Gene therapy 2010;17(5):678-86.
2009: Rebecca A Herbertson; Niall C Tebbutt; Fook-Thean Lee; David J MacFarlane; Bridget Chappell; Noel Micallef; Sze-Ting Lee; Timothy Saunder; Wendie Hopkins; Fiona E Smyth; david wyld; John Bellen; Daryl S Sonnichsen; Martin W Brechbiel; Carmel Murone; Andrew M Scott
Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(21):6709-15.
2009: S T Lee; M Ghanem; R A Herbertson; Salvatore U Berlangieri; Amanda J Byrne; K Tabone; Paul Mitchell; Simon R Knight; Malcolm Feigen; Andrew M Scott
Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(6):473-9.
2009: Hui K Gan; Martha Lappas; Diana X Cao; Anna Cvrljevdic; Andrew M Scott; Terrance G Johns
Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappaB and initiates tumour vascular normalization.
Journal of cellular and molecular medicine 2009;13(9B):3993-4001.
2009: Jennifer A Westwood; William K Murray; Melanie Trivett; Nicole M Haynes; Benjamin Solomon; Linda Mileshkin; David Ball; Michael Michael; Angela Burman; Preethi Mayura-Guru; Joseph A Trapani; Stefan Peinert; Dirk Hönemann; H Miles Prince; Andrew M Scott; Mark J Smyth; Phillip K Darcy; Michael H Kershaw
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(3):292-301.
2009: S Gill; W Cosolo; R A Herbertson; S U Berlangieri; Andrew M Scott
Medullary carcinoma of the thyroid in a patient with colon cancer and a rising carcinoembryonic antigen level.
Internal medicine journal 2009;39(4):264-5.
2009: Thomas P J Garrett; Antony W Burgess; Hui K Gan; Rod B Luwor; Glenn Cartwright; Francesca Walker; Suzanne G Orchard; Andrew H A Clayton; Edouard C Nice; Julie Rothacker; Bruno Catimel; Webster K Cavenee; Lloyd J Old; Elisabeth Stockert; Gerd Ritter; Timothy E Adams; Peter A Hoyne; Dane Wittrup; Ginger Chao; Jennifer Cochran; Cindy Luo; Meizhen Lou; Trevor Huyton; Yibin Xu; W Douglas Fairlie; Shenggen Yao; Andrew M Scott; Terrance G Johns
Antibodies specifically targeting a locally misfolded region of tumor associated EGFR.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(13):5082-7.
2009: Andrew M Scott; Dishan H Gunawardana; Joseph Wong; Ian Kirkwood; Rodney J Hicks; Ivan Ho Shon; Jayne E Ramshaw; Peter Robins
Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study.
European journal of nuclear medicine and molecular imaging 2009;36(3):347-53.
2008: Andrew M Scott; Dishan H Gunawardana; Dylan Bartholomeusz; Jayne E Ramshaw; Peter Lin
PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(10):1593-600.
2008: Andrew M Scott; Dishan H Gunawardana; Ben Kelley; John G Stuckey; Amanda J Byrne; Jayne E Ramshaw; Michael J Fulham
PET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multicenter prospective study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(9):1451-7.
2008: Marcus Kelly; Fook-Thean Lee; Kiki Tahtis; Barbara E Power; Fiona E Smyth; Martin W Brechbiel; Peter J Hudson; Andrew M Scott
Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct.
Cancer biotherapy & radiopharmaceuticals 2008;23(4):411-23.
2008: Jennifer A Westwood; W K Murray; M Trivett; A Shin; P Neeson; D P MacGregor; N M Haynes; Joseph A Trapani; P Mayura-Guru; S Fox; S Peinert; D Honemann; H Miles Prince; D Ritchie; Andrew M Scott; F E Smyth; Mark J Smyth; P K Darcy; Michael H Kershaw
Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice.
Gene therapy 2008;15(14):1056-66.
2008: S T Lee; T Tan; Aurora M T Poon; H B Toh; S Gill; Salvatore U Berlangieri; E Kraft; Amanda J Byrne; Kunthi Pathmaraj; G J O'Keefe; Niall Tebbutt; Andrew M Scott
Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-D-glucose-avid colon lesions.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2008;10(1):48-53.
2007: Rushika M Perera; Roberto Zoncu; Terrance G Johns; Marc Pypaert; Fook-Thean Lee; Ira Mellman; Lloyd J Old; Derek Toomre; Andrew M Scott
Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody.
Neoplasia (New York, N.Y.) 2007;9(12):1099-110.
2007: S T Lee; Salvatore U Berlangieri; Aurora M T Poon; Paul Mitchell; Kunthi Pathmaraj; K Tabone; Amanda J Byrne; Graeme J O'Keefe; Simon R Knight; Charles P Clarke; Andrew M Scott
Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
Internal medicine journal 2007;37(11):753-9.
2007: R A Herbertson; S T Lee; Niall Tebbutt; Andrew M Scott
The expanding role of PET technology in the management of patients with colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1774-81.
2007: Marcus Kelly; Fook-Thean Lee; Kiki Tahtis; Fiona E Smyth; Martin W Brechbiel; Andrew M Scott
Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5604s-5612s.
2007: Christina Cortez; Eva Tomaskovic-Crook; Angus P R Johnston; Andrew M Scott; Edouard C Nice; Joan K Heath; Frank Caruso
Influence of size, surface, cell line, and kinetic properties on the specific binding of A33 antigen-targeted multilayered particles and capsules to colorectal cancer cells.
ACS nano 2007;1(2):93-102.
2007: Andrew M Scott; Niall Tebbutt; Fook-Thean Lee; Tina Cavicchiolo; Zhanqi Liu; Sanjeev Gill; Aurora M T Poon; Wendie Hopkins; Fiona E Smyth; Carmel Murone; Duncan MacGregor; Anthony T Papenfuss; Bridget Chappell; Tim Saunder; Martin W Brechbiel; Ian D Davis; Roger Murphy; Geoffrey Chong; Eric W Hoffman; Lloyd J Old
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3286-92.
2007: Terrance G Johns; Rushika M Perera; Sonja C Vernes; Angela A Vitali; Diana X Cao; Webster K Cavenee; Andrew M Scott; Frank B Furnari
The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1911-25.
2007: Andrew M Scott; Fook-Thean Lee; Niall Tebbutt; Rebecca Herbertson; Sanjeev S Gill; Zhanqi Liu; Effie Skrinos; Carmel Murone; Tim Saunder; Bridget Chappell; Anthony T Papenfuss; Aurora M T Poon; Wendie Hopkins; Fiona E Smyth; Duncan MacGregor; Lawrence M Cher; Achim A Jungbluth; Gerd Ritter; Martin W Brechbiel; Roger Murphy; Antony W Burgess; Eric W Hoffman; Terrance G Johns; Lloyd J Old
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(10):4071-6.
2007: Hui K Gan; Francesca Walker; Antony W Burgess; Angela Rigopoulos; Andrew M Scott; Terrance G Johns
The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806.
The Journal of biological chemistry 2007;282(5):2840-50.
2007: Nathan Lawrentschuk; Ian D Davis; Damien Michael Bolton; Andrew M Scott
Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice.
International journal of urology : official journal of the Japanese Urological Association 2007;14(2):89-95.
2007: Murat Yucel; Warrick J Brewer; Ben Harrison; Alex Fornito; Graeme J O'Keefe; James S Olver; Andrew M Scott; Gary F Egan; Dennis Velakoulis; Patrick D McGorry; Christos Pantelis
Anterior cingulate activation in antipsychotic-naïve first-episode schizophrenia.
Acta psychiatrica Scandinavica 2007;115(2):155-8.
2007: Jianfeng He; Graeme J O'Keefe; Gareth Jones; Tim Saunder; Sylvia J Gong; Moshi Geso; Andrew M Scott
Evaluation of geometrical sensitivity for respiratory motion gating by GATE and NCAT simulation.
Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 2007;2007():4165-8.
2007: Ian D Davis; Zhanqi Liu; Wayne Saunders; Fook-Thean Lee; Violeta Spirkoska; Wendie Hopkins; Fiona E Smyth; Geoffrey Chong; Anthony T Papenfuss; Bridget Chappell; Aurora Poon; Tim Saunder; Eric W Hoffman; Lloyd J Old; Andrew M Scott
A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma.
Cancer immunity 2007;7():14.
2007: Ian D Davis; Gregory A Wiseman; Fook-Thean Lee; Denise N Gansen; Wendie Hopkins; Anthony T Papenfuss; Zhanqi Liu; Timothy J Moynihan; Gary A Croghan; Alex A. Adjei; Eric W Hoffman; James N Ingle; Lloyd J Old; Andrew M Scott
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.
Cancer immunity 2007;7():13.
2006: Martin H Cherk; Serene S Foo; Aurora M T Poon; Simon R Knight; Carmel Murone; Anthony T Papenfuss; John I Sachinidis; Tim Saunder; Graeme J O'Keefe; Andrew M Scott
Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(12):1921-6.
2006: Nathan Lawrentschuk; Aurora M T Poon; Andrew M Scott
Fluorine-18 fluorothymidine: a new positron emission radioisotope for renal tumors.
Clinical nuclear medicine 2006;31(12):788-9.
2006: Junichi Sakamoto; Noboru Oriuchi; Erito Mochiki; Takayuki Asao; Andrew M Scott; Eric W Hoffman; Achim A Jungbluth; Takanori Matsui; Fook-Thean Lee; Anthony T Papenfuss; Hiroyuki Kuwano; Toshitada Takahashi; Keigo Endo; Lloyd J Old
A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma.
Cancer science 2006;97(11):1248-54.
2006: Ben Harrison; Murat Yucel; Marnie Shaw; Michael Kyrios; Paul Maruff; Warrick J Brewer; Rosemary Purcell; Dennis Velakoulis; Stephen C Strother; Andrew M Scott; Pradeep Nathan; Christos Pantelis
Evaluating brain activity in obsessive-compulsive disorder: preliminary insights from a multivariate analysis.
Psychiatry research 2006;147(2-3):227-31.
2006: Andrew G Ellis; M M Doherty; Francesca Walker; Janet Weinstock; Maureen Nerrie; Angela A Vitali; Roger Murphy; Terrance G Johns; Andrew M Scott; A Levitzki; G McLachlan; Lorraine K Webster; Antony W Burgess; Edouard C Nice
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase.
Biochemical pharmacology 2006;71(10):1422-34.
2006: Nathan Lawrentschuk; Ian D Davis; Damien Michael Bolton; Andrew M Scott
Positron emission tomography and molecular imaging of the prostate: an update.
BJU international 2006;97(5):923-31.
2006: Nathan Lawrentschuk; Ian D Davis; Damien Michael Bolton; Andrew M Scott
Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.
BJU international 2006;97(5):916-22.
2006: Marcus Kelly; Fook-Thean Lee; Fiona E Smyth; Martin W Brechbiel; Andrew M Scott
Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(4):716-25.
2006: Lawrence M Cher; Carmel Murone; Nathan Lawrentschuk; Shanker Ramdave; Anthony T Papenfuss; Anthony Hannah; Graeme J O'Keefe; John I Sachinidis; Salvatore U Berlangieri; Gavin Fabinyi; Andrew M Scott
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):410-8.
2006: Nathan Lawrentschuk; Angela Rigopoulos; Fook-Thean Lee; Ian D Davis; Andrew M Scott; Damien Michael Bolton
Xenografting tumour beneath the renal capsule using modern surgical equipment.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 2006;38(3):340-6.
2005: Jennifer A Westwood; Mark J Smyth; Michele W L Teng; Maria Moeller; Joseph A Trapani; Andrew M Scott; Fiona E Smyth; Glenn A Cartwright; Barbara E Power; Dirk Hönemann; H Miles Prince; Phillip K Darcy; Michael H Kershaw
Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(52):19051-6.
2005: Glenn P Ollenberger; Amanda J Byrne; Salvatore U Berlangieri; Christopher C Rowe; Kunthi Pathmaraj; David C Reutens; Samuel F Berkovic; Ingrid E Scheffer; Andrew M Scott
Assessment of the role of FDG PET in the diagnosis and management of children with refractory epilepsy.
European journal of nuclear medicine and molecular imaging 2005;32(11):1311-6.
2005: Fook-Thean Lee; Angela J Mountain; Marcus Kelly; Cathrine Hall; Angela Rigopoulos; Terrance G Johns; Fiona E Smyth; Martin W Brechbiel; Edouard C Nice; Antony W Burgess; Andrew M Scott
Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7080s-7086s.
2005: Rushika M Perera; Yoshitaka Narita; Frank B Furnari; Hui K Gan; Carmel Murone; Marika Ahlkvist; Rodney B Luwor; Antony W Burgess; Elisabeth Stockert; Achim A Jungbluth; Lloyd J Old; Webster K Cavenee; Andrew M Scott; Terrance G Johns
Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6390-9.
2005: Nathan Lawrentschuk; Aurora M T Poon; Serene S Foo; Lydia G Johns Putra; Carmel Murone; Ian D Davis; Damien Michael Bolton; Andrew M Scott
Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography.
BJU international 2005;96(4):540-6.
2005: Kelvin K Yap; Kenneth S K Yap; Amanda J Byrne; Salvatore U Berlangieri; Aurora Poon; Paul Mitchell; Simon R Knight; Peter C Clarke; Anthony Harris; Andrew Tauro; Christopher C Rowe; Andrew M Scott
Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.
European journal of nuclear medicine and molecular imaging 2005;32(9):1033-40.
2005: Marion T Harris; Salvatore U Berlangieri; Jonathan Cebon; Ian D Davis; Andrew M Scott
Impact of 2-deoxy-2[F-18]fluoro-D-glucose Positron Emission Tomography on the management of patients with advanced melanoma.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2005;7(4):304-8.
2005: Geoffrey Chong; Fook-Thean Lee; Wendie Hopkins; Niall Tebbutt; Jonathan Cebon; Angela J Mountain; Bridget Chappell; Anthony T Papenfuss; Paul Schleyer; Paul U; Roger Murphy; Veronika Wirth; Fiona E Smyth; Nicole Potasz; Aurora Poon; Ian D Davis; Tim Saunder; Graeme J O'Keefe; Antony W Burgess; Eric W Hoffman; Lloyd J Old; Andrew M Scott
Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4818-26.
2005: Andrew M Scott; Fook-Thean Lee; Robert Jones; Wendie Hopkins; Duncan MacGregor; Jonathan Cebon; Anthony Hannah; Geoffrey Chong; Paul U; Anthony T Papenfuss; Angela Rigopoulos; Sue Sturrock; Roger Murphy; Veronika Wirth; Carmel Murone; Fiona E Smyth; Simon Knight; Sydney Welt; Gerd Ritter; Elizabeth Richards; Edouard C Nice; Antony W Burgess; Lloyd J Old
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4810-7.
2005: Uwe Ackermann; Henri Tochon-Danguy; Maureen Nerrie; Edouard C Nice; John I Sachinidis; Andrew M Scott
Synthesis, 11C labeling and biological properties of derivatives of the tyrphostin AG957.
Nuclear medicine and biology 2005;32(4):323-8.
2005: Terrance G Johns; Ira Mellman; Glenn A Cartwright; Gerd Ritter; Lloyd J Old; Antony W Burgess; Andrew M Scott
The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(7):780-2.
2005: C Panousis; V M Rayzman; Terrance G Johns; C Renner; Zhanqi Liu; Glenn A Cartwright; Fook-Thean Lee; D Wang; Hui K Gan; D Cao; A Kypridis; Fiona E Smyth; Martin W Brechbiel; Antony W Burgess; Lloyd J Old; Andrew M Scott
Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR.
British journal of cancer 2005;92(6):1069-77.
2005: Fiona O Roberts; Dishan H Gunawardana; Kunthi Pathmaraj; Anthony Wallace; Paul U; Tian Mi; Salvatore U Berlangieri; Graeme J O'Keefe; Christopher C Rowe; Andrew M Scott
Radiation dose to PET technologists and strategies to lower occupational exposure.
Journal of nuclear medicine technology 2005;33(1):44-7.
2005: Andrew M Scott; Zhanqi Liu; Carmel Murone; Terrance G Johns; Duncan MacGregor; Fiona E Smyth; Fook-Thean Lee; Jonathan Cebon; Ian D Davis; Wendie Hopkins; Angela J Mountain; Angela Rigopoulos; Nobuo Hanai; Lloyd J Old
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.
Cancer immunity 2005;5():3.
2005: Roger Murphy; Simon Green; Gerd Ritter; L Cohen; D Ryan; W Woods; M Rubira; Jonathan Cebon; Ian D Davis; A Sjolander; A Kypridis; H Kalnins; M McNamara; M B Moloney; J Ackland; Glenn A Cartwright; J Rood; G Dumsday; K Healey; D Maher; Eugene Maraskovsky; Yao-Tseng Chen; Eric W Hoffman; Lloyd J Old; Andrew M Scott
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.
Preparative biochemistry & biotechnology 2005;35(2):119-34.
2004: L Johns Putra; L Johns Putra; Nathan Lawrentschuk; Z Ballok; Anthony Hannah; Aurora Poon; A Tauro; Ian D Davis; R J Hicks; Damien Michael Bolton; Andrew M Scott
18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy.
Urology 2004;64(6):1202-7.
2004: W Issa; Henri Tochon-Danguy; J Lambert; John I Sachinidis; Uwe Ackermann; Z Liu; Andrew M Scott
Synthesis and evaluation of a thymidine analog for positron emission tomography study of tumor DNA proliferation in vivo.
Nuclear medicine and biology 2004;31(7):839-49.
2004: Serene S Foo; David F Abbott; Nathan Lawrentschuk; Andrew M Scott
Functional imaging of intratumoral hypoxia.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2004;6(5):291-305.
2004: Rodney B Luwor; Hong-Jian Zhu; Francesca Walker; Angela A Vitali; Rushika M Perera; Antony W Burgess; Andrew M Scott; Terrance G Johns
The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR.
Oncogene 2004;23(36):6095-104.
2004: Ian D Davis; Weisan Chen; Heather Jackson; Phillip Parente; Mark Shackleton; Wendie Hopkins; Qiyuan Chen; Nektaria Dimopoulos; Tina Luke; Roger Murphy; Andrew M Scott; Eugene Maraskovsky; Grant McArthur; Duncan MacGregor; Sue Sturrock; Tsin Yee Tai; Simon Green; Andrew Cuthbertson; Darryl Maher; Lena Miloradovic; Susan V Mitchell; Gerd Ritter; Achim A Jungbluth; Yao-Tseng Chen; Sacha Gnjatic; Eric W Hoffman; Lloyd J Old; Jonathan Cebon
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(29):10697-702.
2004: Terrance G Johns; Timothy E Adams; Jennifer Cochran; Nathan E Hall; Peter A Hoyne; Mark J Olsen; Yong-Sung Kim; Julie Rothacker; Edouard C Nice; Francesca Walker; Gerd Ritter; Achim A Jungbluth; Lloyd J Old; Colin W Ward; Antony W Burgess; K Dane Wittrup; Andrew M Scott
Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor.
The Journal of biological chemistry 2004;279(29):30375-84.
2004: Serene S Foo; P L Mitchell; Salvatore U Berlangieri; C L Smith; Andrew M Scott
Positron emission tomography scanning in the assessment of patients with lymphoma.
Internal medicine journal 2004;34(7):388-97.
2004: Serene S Foo; Shankar Ramdave; Salvatore U Berlangieri; Andrew M Scott
Detection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography.
Australasian radiology 2004;48(2):214-6.
2004: Francesca Walker; Suzanne G Orchard; Robert N Jorissen; Nathan E Hall; Hui-Hua Zhang; Peter A Hoyne; Timothy E Adams; Terrance G Johns; Colin Ward; Thomas P J Garrett; Hong-Jian Zhu; Maureen Nerrie; Andrew M Scott; Edouard C Nice; Antony W Burgess
CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.
The Journal of biological chemistry 2004;279(21):22387-98.
2003: Terrance G Johns; Rodney B Luwor; Carmel Murone; Francesca Walker; Janet Weinstock; Angela A Vitali; Rushika M Perera; Achim A Jungbluth; Elisabeth Stockert; Lloyd J Old; Edouard C Nice; Antony W Burgess; Andrew M Scott
Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(26):15871-6.
2003: Zhanqi Liu; Con Panousis; Fiona E Smyth; Roger Murphy; Veronika Wirth; Glenn A Cartwright; Terrance G Johns; Andrew M Scott
Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses.
Hybridoma and hybridomics 2003;22(4):219-28.
2003: Kiki Tahtis; Fook-Thean Lee; Jennifer M Wheatley; Pilar Garin-Chesa; John E Park; Fiona E Smyth; Yuichi Obata; Elisabeth Stockert; Cathrine M Hall; Lloyd J Old; Wolfgang J Rettig; Andrew M Scott
Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model.
Molecular cancer therapeutics 2003;2(8):729-37.
2003: Fook-Thean Lee; Andrew M Scott
Immuno-PET for tumor targeting.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(8):1282-3.
2003: Paul Mitchell; Fook-Thean Lee; Cathrine Hall; Angela Rigopoulos; Fiona E Smyth; Anne-Marie Hekman; Gijs M van Schijndel; Ray Powles; Martin W Brechbiel; Andrew M Scott
Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(7):1105-12.
2003: Andrew M Scott; Greg Wiseman; Sydney Welt; Alex A. Adjei; Fook-Thean Lee; Wendie Hopkins; Chaitanya R Divgi; Lorelei H Hanson; Paul Mitchell; Denise N Gansen; Steven M Larson; James N Ingle; Eric W Hoffman; Paul Tanswell; Gerd Ritter; Leonard S Cohen; Peter Bette; Lisa Arvay; Andree Amelsberg; Dan Vlock; Wolfgang J Rettig; Lloyd J Old
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1639-47.
2003: Barbara E Power; Larissa Doughty; Deborah Shapira; John E Burns; Ann M Bayly; Joanne M Caine; Zhanqi Liu; Andrew M Scott; Peter J Hudson; Alexander A Kortt
Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.
Protein science : a publication of the Protein Society 2003;12(4):734-47.
2002: Zhanqi Liu; Fook-Thean Lee; Nobuo Hanai; Fiona E Smyth; Antony W Burgess; Lloyd J Old; Andrew M Scott
Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
Cancer immunity 2002;2():13.
2002: Rey Casse; Christopher C Rowe; Mark Newton; Salvatore U Berlangieri; Andrew M Scott
Positron emission tomography and epilepsy.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2002;4(5):338-51.
2002: Anthony Hannah; Andrew M Scott; Henri Tochon-Danguy; J Gordon Chan; Timothy Akhurst; Salvatore Berlangieri; David Price; Gerard J Smith; Tony Schelleman; WJ McKay; Andrew Sizeland
Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
Annals of surgery 2002;236(2):208-17.
2002: Andrew M Scott
Current status of positron emission tomography in oncology.
Australasian radiology 2002;46(2):154-62.
2002: Romesh Markus; Geoffrey A Donnan; Seiji Kazui; Stephen Read; T Hirano; Andrew M Scott; Graeme J O'Keefe; Henri Tochon-Danguy; John I Sachinidis; David C Reutens
Statistical parametric mapping of hypoxic tissue identified by [(18)F]fluoromisonidazole and positron emission tomography following acute ischemic stroke.
NeuroImage 2002;16(2):425-33.
2002: Zhanqi Liu; Fiona E Smyth; Christoph Renner; Fook-Thean Lee; Egbert Oosterwijk; Andrew M Scott
Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity.
Cancer immunology, immunotherapy : CII 2002;51(3):171-7.
2002: Terrance G Johns; Elisabeth Stockert; Gerd Ritter; Achim A Jungbluth; H-J Su Huang; Webster K Cavenee; Fiona E Smyth; Cathrine M Hall; Nadine Watson; Edouard C Nice; William J Gullick; Lloyd J Old; Antony W Burgess; Andrew M Scott
Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.
International journal of cancer. Journal international du cancer 2002;98(3):398-408.
2002: Henri Tochon-Danguy; John I Sachinidis; Fiona Chan; J Gordon Chan; Catherine Hall; Lawrence M Cher; Stanley Stylli; John Hill; Andrew Kaye; Andrew M Scott
Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO).
Nuclear medicine and biology 2002;29(2):191-7.
2001: Marisa Gallicchio; Malea Kneen; C Hall; Andrew M Scott; Leon A Bach
Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo.
International journal of cancer. Journal international du cancer 2001;94(5):645-51.
2001: Andrew M Scott; Fook-Thean Lee; Wendie Hopkins; Jonathan Cebon; J M Wheatley; Zhanqi Liu; Fiona E Smyth; Carmel Murone; Sue Sturrock; Duncan MacGregor; Nobuo Hanai; K Inoue; M Yamasaki; Martin W Brechbiel; Ian D Davis; Roger Murphy; Anthony Hannah; M Lim-Joon; T Chan; Geoffrey Chong; Gerd Ritter; Eric W Hoffman; Antony W Burgess; Lloyd J Old
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3976-87.
2001: S Ramdave; G W Thomas; Salvatore U Berlangieri; D M Bolton; I Davis; H T Danguy; D Macgregor; Andrew M Scott
Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
The Journal of urology 2001;166(3):825-30.
2001: Rodney B Luwor; Terrance G Johns; Carmel Murone; H-J Su Huang; Webster K Cavenee; Gerd Ritter; Lloyd J Old; Antony W Burgess; Andrew M Scott
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.
Cancer research 2001;61(14):5355-61.
2001: Kazuhiko Mishima; Terrance G Johns; Rodney B Luwor; Andrew M Scott; Elisabeth Stockert; Achim A Jungbluth; XD Ji; P Suvarna; J R Voland; Lloyd J Old; H-J Su Huang; Webster K Cavenee
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
Cancer research 2001;61(14):5349-54.
2001: Barbara E Power; J M Caine; John E Burns; Deborah Shapira; Meghan Hattarki; Kiki Tahtis; Fook-Thean Lee; Fiona E Smyth; Andrew M Scott; Alexander A Kortt; Peter J Hudson
Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector.
Cancer immunology, immunotherapy : CII 2001;50(5):241-50.
2001: Fook-Thean Lee; Angela Rigopoulos; Cathrine Hall; K Clarke; Stephen H Cody; Fiona E Smyth; Zhanqi Liu; Martin W Brechbiel; Nobuo Hanai; Edouard C Nice; Bruno Catimel; Antony W Burgess; Sydney Welt; Gerd Ritter; Lloyd J Old; Andrew M Scott
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Cancer research 2001;61(11):4474-82.
2001: Fook-Thean Lee; Cathrine Hall; Angela Rigopoulos; J Zweit; Kunthi Pathmaraj; Graeme J O'Keefe; Fiona E Smyth; Sydney Welt; Lloyd J Old; Andrew M Scott
Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(5):764-9.
2001: C Renner; I Stehle; Fook-Thean Lee; Cathrine Hall; Bruno Catimel; Edouard C Nice; Angela J Mountain; Angela Rigopoulos; Martin W Brechbiel; Michael Pfreundschuh; Andrew M Scott
Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo system.
Cancer immunology, immunotherapy : CII 2001;50(2):102-8.
2001: Kiki Tahtis; Fook-Thean Lee; Fiona E Smyth; Barbara E Power; C Renner; Martin W Brechbiel; Lloyd J Old; Peter J Hudson; Andrew M Scott
Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):1061-72.
2001: Andrew M Scott
Current status of positron emission tomography in oncology.
Internal medicine journal 2001;31(1):27-36.
2000: K Clarke; Fook-Thean Lee; Martin W Brechbiel; Fiona E Smyth; Lloyd J Old; Andrew M Scott
Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3621-8.
2000: K Clarke; Fook-Thean Lee; Martin W Brechbiel; Fiona E Smyth; Lloyd J Old; Andrew M Scott
In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
Cancer research 2000;60(17):4804-11.
2000: Stephen J Read; T Hirano; David F Abbott; Romesh Markus; John I Sachinidis; Henri Tochon-Danguy; J Gordon Chan; Gary F Egan; Andrew M Scott; Christopher F Bladin; WJ McKay; Geoffrey A Donnan
The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke.
Annals of neurology 2000;48(2):228-35.
2000: Andrew M Scott; DM Geleick; M Rubira; K Clarke; Edouard C Nice; Fiona E Smyth; Elisabeth Stockert; E C Richards; F J Carr; W J Harris; Kathryn Armour; J Rood; A Kypridis; V Kronina; Roger Murphy; Fook-Thean Lee; Zhanqi Liu; K Kitamura; Gerd Ritter; K Laughton; Eric Hoffman; Antony W Burgess; Lloyd J Old
Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
Cancer research 2000;60(12):3254-61.
2000: Marc G Achen; Sally Roufail; Teresa Domagala; Bruno Catimel; Edouard C Nice; DM Geleick; Roger Murphy; Andrew M Scott; Carol Caesar; Taija Makinen; Kari Alitalo; Steven A Stacker
Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.
European journal of biochemistry / FEBS 2000;267(9):2505-15.
2000: Anthony Hannah; Malcolm Feigen; George G Quong; Timothy Akhurst; Salvatore U Berlangieri; A Zimet; J Zalcberg; WJ McKay; Andrew M Scott
Use of [F]-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2000;122(2):304-6.
1999: T Hirano; Stephen J Read; David F Abbott; John I Sachinidis; Henri Tochon-Danguy; Gary F Egan; Christopher F Bladin; Andrew M Scott; WJ McKay; Geoffrey A Donnan
No evidence of hypoxic tissue on 18F-fluoromisonidazole PET after intracerebral hemorrhage.
Neurology 1999;53(9):2179-82.
1999: Henri Tochon-Danguy; John I Sachinidis; Gary F Egan; J Gordon Chan; Salvatore U Berlangieri; WJ McKay; Andrew M Scott
Positron emission tomography: radioisotope and radiopharmaceutical production.
Australasian physical & engineering sciences in medicine / supported by the Australasian College of Physical Scientists in Medicine and the Australasian Association of Physical Sciences in Medicine 1999;22(4):136-44.
1999: Salvatore U Berlangieri; Andrew M Scott; Simon R Knight; G J Fitt; O F Hennessy; Henri Tochon-Danguy; Charles P Clarke; WJ McKay
F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 1999;16 Suppl 1():S25-30.
1998: Stephen J Read; T Hirano; David F Abbott; John I Sachinidis; Henri Tochon-Danguy; J Gordon Chan; Gary F Egan; Andrew M Scott; Christopher F Bladin; WJ McKay; Geoffrey A Donnan
Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole.
Neurology 1998;51(6):1617-21.
1998: Bruno Catimel; Andrew M Scott; Fook-Thean Lee; Nobuo Hanai; Gerd Ritter; Sydney Welt; Lloyd J Old; Antony W Burgess; Edouard C Nice
Direct immobilization of gangliosides onto gold-carboxymethyldextran sensor surfaces by hydrophobic interaction: applications to antibody characterization.
Glycobiology 1998;8(9):927-38.
1998: John D Kiffer; Salvatore U Berlangieri; Andrew M Scott; George G Quong; Malcolm Feigen; Wendy A Schumer; Charles P Clarke; Simon R Knight; F J Daniel
The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer.
Lung cancer (Amsterdam, Netherlands) 1998;19(3):167-77.
1997: Andrew M Scott; Sydney Welt
Antibody-based immunological therapies.
Current opinion in immunology 1997;9(5):717-22.
1997: Bruno Catimel; Maureen Nerrie; F T Lee; Andrew M Scott; G Ritter; Sydney Welt; Lloyd J Old; Antony W Burgess; Edouard C Nice
Kinetic analysis of the interaction between the monoclonal antibody A33 and its colonic epithelial antigen by the use of an optical biosensor. A comparison of immobilisation strategies.
Journal of chromatography. A 1997;776(1):15-30.
1997: Andrew M Scott; Jonathan Cebon
Clinical promise of tumour immunology.
Lancet 1997;349 Suppl 2():SII19-22.
1997: Joan K Heath; Sara J White; Cameron N Johnstone; Bruno Catimel; Richard J Simpson; Robert L Moritz; G F Tu; H Ji; RH Whitehead; L C Groenen; Andrew M Scott; Gerd Ritter; L Cohen; Sydney Welt; Lloyd J Old; Edouard C Nice; Antony W Burgess
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):469-74.